# NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)

> **NCT01654250** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 90 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** NWP09
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01654250
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2016-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654250, "NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01654250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*